Patients without diabetes using GLP-1RAs are less likely to develop glaucoma compared with those who use other weight loss therapies.

Akums has launched a pioneering treatment for glaucoma in India. The new eye drops combines two treatments in one drop, ...

The EMA’s Committee for Medicinal Products for Human Use said that a phase 3 study in children aged 3-14 years demonstrated ...

Young adults with myopia who attend school may benefit from lower concentration atropine, which minimizes visual performance disruptions.

Sepetaprost demonstrated noninferiority to timolol 0.5% in decreasing intraocular pressure for patients with glaucoma or ocular hypertension.

Retinitis pigmentosa (RP) is a rare inherited condition that causes the gradual death of photoreceptors (light-sensing cells) ...